Document is current

Any future updates will be listed below

A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study

Crossref DOI link: https://doi.org/10.1007/s11523-022-00884-z

Published Online: 2022-05-30

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark